| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |